Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84-Reference-Cited by-同舟云学术

Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84

Published:1998-06 Issue:7 Volume:34 Page:1050-1062
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Flamant F,Rodary C,Rey A,Praquin M.-T,Sommelet D,Quintana E,Theobald S,Brunat-Mentigny M,Otten J,Voûte P.A,Habrand J.L,Martelli H,Barrett A,Terrier-Lacombe M.-J,Oberlin O

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Incidence of malignant tumours in United States children;Young;J Pediatr,1975

2. The value of adjuvant chemotherapy in the management of sarcomas in children;Donaldson;Cancer,1985

3. The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma. A historical comparison of 345 patients treated in the same center;Flamant;Cancer,1984

4. Heyn R, Raney RB, Hays DM, et al. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. J Clin Oncol 1992, 10, 614–623.

5. Heyn R, Ragab A, Raney RB, et al. Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study. Cancer 1986, 57, 1738–1743.

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma;International Journal of Clinical Oncology;2024-08-23

2. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

3. Uncovering a Novel Site of Ewing’s Sarcoma: the Hypopharynx;Indian Journal of Otolaryngology and Head & Neck Surgery;2023-05-10

4. Long‐term results from the multicentric European randomized phase 3 trial CWS/RMS‐96 for localized high‐risk soft tissue sarcoma in children, adolescents, and young adults;Pediatric Blood & Cancer;2022-04-19

5. Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor;Cancers;2021-03-22